Walgreen (NYSE:WAG) said Thursday its same-store sales climbed 7.5% in June, citing strength in the pharmacy segment.
Continue Reading Below
The nation’s largest drugstore recently reported better earnings for the third quarter amid higher sales of prescription drugs. However, the results missed expectations as a less pronounced shift to generic drugs hurt margins.
Drug retailers have been faced with lower drug sales with more generics hitting the market. Generic drugs are typically cheaper than brand-name products, although they also bring higher margins.
Deerfield, Ill.-based Walgreen booked overall sales of $6.28 billion last month, up 8.9% over the year-ago month. Same-store sales in the pharmacy section were up 11.3%, and prescriptions filled grew 7.3%. Pharmacy sales generated 65.2% of total revenue in June.
At the front of the store, same-store sales ticked 1.3% higher. Comparable traffic fell 2%, while basket size improved 3.3%.
Shares of Walgreen were trading 1.3% higher at $74.02.